Fate Therapeutics Inc at Jefferies Healthcare Conference (Virtual) Transcript
All right. Well, good afternoon, everyone, and thank you for joining us on our next session. Today, we've got both the CEO, Scott Wolchko; and CFO, Edward Dulac from Fate Therapeutics, a company has certainly been super busy this year with data recently presented and more this month.
So without further ado, I would love to just start off with Scott. And maybe, Scott, you could start maybe with some opening comments about how the Fate platform is progressing with perhaps a focus on data that's been presented recently and data coming up because this is really a big year. I call it last year sort of a breakout year, and this year is sort of a full court press type of year of a lot of data. So maybe just walk us through the progress of Fate and particularly the focus on recent data and what's coming up. That would be a great place to start.
Sure. And I'll do this briefly. So Fate helped pioneer iPS
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |